Clinical Trials on Graves Disease in Canada

Total 25096 results

University of Alberta
Medtronic - MITG

Completed

A Prospective Randomized Equivalence Trial to Evaluate the Safety of the Ligasure in Thyroid Surgery

Thyroid Nodule | Grave's Disease | Multinodular Goitre

Canada
University Health Network, Toronto

Completed

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

Graves Disease | Thyroid Cancer | Thyroid Goiter

Canada
Immunovant Sciences GmbH

Completed

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Graves' Ophthalmopathy

Canada
University of Toronto
Allergan

Withdrawn

Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction

Graves Ophthalmopathy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada
University Health Network, Toronto
Grifols Therapeutics LLC

Completed

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

Myasthenia Gravid

Canada
University of Waterloo
University of Mississippi Medical Center; Travel Health Network

Completed

Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic

Travel Medicine

Canada
Immunovant Sciences GmbH

Terminated

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Graves' Ophthalmopathy (GO)

United States, Germany, Spain, Canada, Italy
Worg Biotherapeutics Inc.

Recruiting

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Graves Disease

United States
Hoffmann-La Roche

Recruiting

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2) (SatraGO-2)

Thyroid Eye Disease

Korea, Republic of, United Kingdom, United States, Canada, China, Israel, France, Spain
University Health Network, Toronto
Zogenix, Inc.

Not yet recruiting

Fenfluramine for Adult Dravet Patients

Dravet Syndrome | Dravet Syndrome, Intractable

Canada
Sling Therapeutics, Inc.

Active, not recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Italy, United Kingdom, Canada
McMaster University

Recruiting

Defining Decision Thresholds for Judgments on Health Benefits and Harms: Study Protocol

Decision Support Techniques | GRADE Approach

Canada
Children's Hospital of Eastern Ontario
Canadian Institutes of Health Research (CIHR)

Completed

Active Video Games and Appetite Control in Adolescents

Active Video Games and Appetite Control

Canada
Circassia Limited
Adiga Life Sciences, Inc.; Pharm-Olam International

Completed

ToleroMune Grass Exposure Unit Study

Grass Allergy | Rhinoconjunctivitis

Canada
McMaster University

Completed

New Alternative Formats vs Standard of SoF Tables. Non-inferiority Controlled Trial

GRADE Approach | Summary of Findings Table | Cochrane Collaboration

Canada
Jesús María Villar del Moral

Completed

Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. (LIGRADIS)

Hyperthyroidism, Autoimmune

Spain
University Health Network, Toronto

Unknown

Atherectomy and Drug Coated Balloon for the Treatment of Arterio-Venous Graft Stenosis

Dysfunctional Arterial-venous Grafts

Canada
Alan Nichol

Completed

Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study

Cancer (High-grace Glioma)

Canada
Immunovant Sciences GmbH

Recruiting

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

Thyroid Eye Disease

United States, Italy, Poland, United Kingdom, Canada, Israel, Germany, Japan, Georgia
Viridian Therapeutics, Inc.

Active, not recruiting

A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States, Spain, United Kingdom, Canada, Germany, Italy, Netherlands, Australia, France, Turkey
National Cancer Institute (NCI)

Completed

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Recurrent Salivary Gland Cancer | Recurrent Adenoid Cystic Carcinoma of the Oral Cavity | High-grade Salivary Gland Carcinoma | High-grade Salivary Gland Mucoepidermoid Carcinoma | Low-grade Salivary Gland Carcinoma | Low-grade Salivary Gland Mucoepidermoid Carcinoma | Salivary Gland Acinic Cell... and other conditions

Canada
University of Alberta
CSL Behring

Completed

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) (SCIG-MG)

Myasthenia Gravis

Canada
University Health Network, Toronto

Recruiting

Subcutaneous Immunoglobulin for Myasthenia Gravis (MG_SCIG)

Myasthenia Gravis

Canada
University Health Network, Toronto

Completed

Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis

Myasthenia Gravis

Canada
Alberta Health services

Completed

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Low Grade Lymphoma

Canada
Queen's University
Hotel Dieu Hospital (Gastrointestinal Diseases Research Unit)

Completed

Improving Bowel Preparation for the Colon Capsule

Quality of Bowel Preparation for the Colon Capsule | Colon Capsule Completion Rates | Colon Capsule Polyp Detection

Canada
Mount Sinai Hospital, Canada
London Health Sciences Centre; Royal Alexandra Hospital; Foothills Medical Centre

Recruiting

Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy (PIONIRS)

Intraventricular Hemorrhage of Newborn Grade 2 | Intraventricular Hemorrhage of Newborn Grade 3 | Intraventricular Haemorrhage Grade IV

Canada
University Health Network, Toronto

Recruiting

Circulating Tumor DNA Collection From Patients With High Grade Gliomas (m-ctDNA)

High Grade Glioma

Canada
Sunnybrook Health Sciences Centre

Recruiting

CEST in Low-grade Glioma Study

Low-grade Glioma

Canada
Ottawa Hospital Research Institute
Ontario Ministry of Health and Long Term Care; Children's Hospital of Eastern...

Completed

BEST ABCs: Benefits and Effectiveness of Support Offered Through A Breastfeeding Clinic Study (BEST ABCs)

Neonatal Jaundice | Exclusive Breastfeeding Rates

Canada
Saint Thomas Hospital, Panama

Completed

Observational vs. Ablative Treatment for Low-grade Squamous Intraepithelial Lesions.

LSIL, Low-Grade Squamous Intraepithelial Lesions

Panama
National Cancer Institute (NCI)

Active, not recruiting

Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular Lymphoma

United States, Canada, Singapore
Novartis Pharmaceuticals

Completed

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

Myasthenia Gravis, Generalized

Taiwan, Germany, Russian Federation, Denmark, Canada
Mansoura University

Completed

Diaphragm Thickness by Ultrasonography in Neurological Disorders

Myasthenia Gravis | Guillain-Barre Syndrome

Egypt
CHU de Quebec-Universite Laval
Prostate Cancer Canada

Active, not recruiting

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression

Prostatic Neoplasms | Low Grade Prostate Cancer

Canada
Michael Benatar
University of Miami; University of Rochester

Terminated

Efficacy of Prednisone In the Treatment of Ocular Myasthenia (EPITOME')

Ocular Myasthenia Gravis

United States, Canada
Daniel Morgenstern
The Hospital for Sick Children

Recruiting

Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas (VICTORY)

Low-grade Glioma

Canada
Vivifi Medical
RQMplus

Not yet recruiting

Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis

Benign Prostatic Hyperplasia | Varicocele Grade II | Varicocele Grade III

Panama
University Health Network, Toronto
GlaxoSmithKline

Recruiting

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid Cancer

Canada
GlaxoSmithKline

Completed

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Myasthaenia Gravis

United States, Canada, Germany, Italy
Cartesian Therapeutics

Recruiting

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Myasthenia Gravis, Generalized

United States, Canada
Ad scientiam

Recruiting

Descriptive Analysis of Real-world Data Collected With ME&MGopen

Myasthenia Gravis

United Kingdom, United States, Canada
Centre hospitalier de l'Université de Montréal...
Canadian Institutes of Health Research (CIHR); Terry Fox Foundation

Active, not recruiting

Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers (CoHIPP)

High Grade Cervical Intra-epithelial Neoplasia

Canada
UCB Biopharma SRL

Completed

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

Generalized Myasthenia Gravis

United States, Canada, Georgia, Germany, Italy, Japan, Poland, Serbia, Spain, United Kingdom
argenx

Recruiting

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United Kingdom, Spain, United States, Austria, Germany, Belgium, Italy, Netherlands, France, Georgia, Poland, Canada
National Cancer Institute (NCI)

Completed

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

Canada
Sunnybrook Health Sciences Centre

Completed

Overlooked Population at Risk for AIN.

Cervical Cancer | High Grade Cervical Dysplasia

Canada
Grifols Therapeutics LLC

Completed

A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations

Myasthenia Gravis Exacerbations

Belgium, Poland, Canada, Argentina, Estonia, France, Hungary, Romania, Czechia, Latvia, Russian Federation, South Africa
Ra Pharmaceuticals

Completed

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Canada

Clinical Trials on Graves Disease in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations